Cyclopharm (CYC.AX) jumps 10.9% on Chinese medical groups backing Technegas
Shares of Australian radiopharmaceutical company Cyclopharm jumped as much as 10.9% to A$0.510 on Monday, marking their largest intraday percentage gain since September 14. The rise followed the joint publication of a consensus by seven Chinese medical bodies recommending Cyclopharm's Technegas ventilation imaging agen